These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2712146)

  • 1. Systemic absorption of ophthalmic cyclopentolate.
    Kaila T; Huupponen R; Salminen L; Iisalo E
    Am J Ophthalmol; 1989 May; 107(5):562-4. PubMed ID: 2712146
    [No Abstract]   [Full Text] [Related]  

  • 2. Systemic absorption of ocular cyclopentolate in children.
    Lahdes K; Huupponen R; Kaila T; Ali-Melkkilä T; Salminen L; Saari M
    Ger J Ophthalmol; 1992; 1(1):16-8. PubMed ID: 1477610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ocular effects and systemic absorption of cyclopentolate eyedrops after canthal and conventional application.
    Lahdes KK; Huupponen RK; Kaila TJ
    Acta Ophthalmol (Copenh); 1994 Dec; 72(6):698-702. PubMed ID: 7747578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pupillary dilation with single eyedrop mydriatic combinations.
    Brenner RL
    Am J Ophthalmol; 1980 Aug; 90(2):271-2. PubMed ID: 7425044
    [No Abstract]   [Full Text] [Related]  

  • 5. Plasma concentrations and ocular effects of cyclopentolate after ocular application of three formulations.
    Lahdes K; Huupponen R; Kaila T; Monti D; Saettone MF; Salminen L
    Br J Clin Pharmacol; 1993 May; 35(5):479-83. PubMed ID: 8512760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic and ocular absorption and antagonist activity of topically applied cyclopentolate in man.
    Haaga M; Kaila T; Salminen L; Ylitalo P
    Pharmacol Toxicol; 1998 Jan; 82(1):19-22. PubMed ID: 9527641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of the time interval between instillation of two drops of cyclopentolate 1% on refraction and dilation of the pupil in children.
    Stolovitch C; Alster Y; Loewenstein A; Lazar M
    Am J Ophthalmol; 1995 May; 119(5):637-9. PubMed ID: 7733189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effects on accommodative and pupillary responses by topical application of cyclopentolate hydrochloride].
    Ohmi G; Kinoshita H; Kinoshita S
    Nippon Ganka Gakkai Zasshi; 1991 Nov; 95(11):1099-104. PubMed ID: 1759650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic Absorption of Cyclopentolate and Adverse Events After Retinopathy of Prematurity Exams.
    Mitchell A; Hall RW; Erickson SW; Yates C; Lowery S; Hendrickson H
    Curr Eye Res; 2016 Dec; 41(12):1601-1607. PubMed ID: 27159349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of 0.5% cyclopentolate plus 0.5% tropicamide and 1% cyclopentolate alone for mydriasis of dark irides.
    Nishizawa AR; Orton RB; Cadera W
    Can J Ophthalmol; 1988 Dec; 23(7):299-300. PubMed ID: 3228775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pupillary dilatation with single eyedrop mydriatic combinations.
    Apt L; Henrick A
    Am J Ophthalmol; 1980 Apr; 89(4):553-9. PubMed ID: 7369319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic toxicity of cyclopentolate hydrochloride in adults following topical ocular instillation.
    Awan KJ
    Ann Ophthalmol; 1976 Jul; 8(7):803-6. PubMed ID: 962257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dilation efficacy: is 1% cyclopentolate enough?
    Hug T; Olitsky S
    Optometry; 2007 Mar; 78(3):119-21. PubMed ID: 17321460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Niosomes as carriers for ophthalmic drugs: in vitro/in vivo evaluation.
    Perini G; Saettone MF; Carafa M; Santucci E; Alhaique F
    Boll Chim Farm; 1996 Feb; 135(2):145-6. PubMed ID: 8791827
    [No Abstract]   [Full Text] [Related]  

  • 15. CLINICAL EVALUATION OF A NEW MYDRIATIC-MYDRILATE.
    Cowan EC; Archer D
    Br J Ophthalmol; 1962 Dec; 46(12):730-6. PubMed ID: 18170843
    [No Abstract]   [Full Text] [Related]  

  • 16. Reduction in mydriatic drop size in premature infants.
    Wheatcroft S; Sharma A; McAllister J
    Br J Ophthalmol; 1993 Jun; 77(6):364-5. PubMed ID: 8318484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute psychosis associated with topical cyclopentolate hydrochloride.
    Khurana AK; Ahluwalia BK; Rajan C; Vohra AK
    Am J Ophthalmol; 1988 Jan; 105(1):91. PubMed ID: 3337198
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of mydriatics on intraocular pressure and pupil size in the normal feline eye.
    Stadtbäumer K; Frommlet F; Nell B
    Vet Ophthalmol; 2006; 9(4):233-7. PubMed ID: 16771758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of cycloplegic agents: results of a randomized controlled trial in nigerian children.
    Ebri A; Kuper H; Wedner S
    Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1025-31. PubMed ID: 17325142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective comparison between cyclopentolate spray and drops in pediatric outpatients.
    Syrimi M; Jones SM; Thompson GM
    J Pediatr Ophthalmol Strabismus; 2013; 50(5):290-5. PubMed ID: 23705592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.